4,593 articles in this topic
A comprehensive review covers MNV origins, multimodal imaging diagnosis, and anti-VEGF therapies for macular diseases threatening central vision.
Go beyond the basics and explore the molecular machinery of the Unfolded Protein Response — three distinct signaling branches that determine whether a stressed cell recovers, adapts, or dies.
A placebo-controlled trial found high-dose DHA omega-3 reached the brain but did not improve cognition or brain volume over 24 months.
New cardiology research links DNA methylation clocks to heart failure progression and chewing sugar gum may amplify nitrate vegetable benefits.
A CDC-blocked vaccine effectiveness study finds 2025-2026 COVID shots cut hospitalization risk by 55% and ER visits by 50% in adults.
A Nature Medicine study finds younger generations are biologically older than their parents at the same age, raising early-onset cancer risk by up to 57%.
Innovent's IBI3003 targets three cancer proteins at once, showing 83% response rates in early trials for hard-to-treat blood cancer.
Singapore scientists developed a fluorescent nanosensor that rapidly measures a key gut microbiome molecule linked to inflammation and metabolic health.
A landmark $2.5B AI drug discovery deal targets neuroimmune disorders, potentially cutting development timelines from 4 years to 18 months.
A longevity biotech targets skin aging via TORC1 modulation, raising $20M to commercialize its Re-Q serum backed by serious geroscience.
A completed trial examines how a key inflammation pathway connects periodontitis stages to the chronic low-grade inflammation of aging.
A comprehensive review of how aging reshapes immunity and which vaccine strategies—adjuvants, high-dose, mRNA—best overcome those changes.
